These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25481105)

  • 1. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
    Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
    Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
    Natarajan A; Christopher R; Netravathi M; Bhat MD; Chandra SR
    Clin Chim Acta; 2019 Aug; 495():167-173. PubMed ID: 30980791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
    Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
    Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
    Haynes CA; De Jesús VR
    Clin Chim Acta; 2012 Aug; 413(15-16):1217-21. PubMed ID: 22503909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
    Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
    Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation, and clinical application of an FIA-MS/MS method for the quantification of lysophosphatidylcholines in dried blood spots.
    Yue X; Liu W; Liu Y; Shen M; Zhai Y; Ma Z; Cao Z
    J Clin Lab Anal; 2022 Jan; 36(1):e24099. PubMed ID: 34788474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
    Wang Y; Tian G; Ji W; Wang S; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
    Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
    Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
    Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
    J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.
    Hubbard WC; Moser AB; Liu AC; Jones RO; Steinberg SJ; Lorey F; Panny SR; Vogt RF; Macaya D; Turgeon CT; Tortorelli S; Raymond GV
    Mol Genet Metab; 2009 Jul; 97(3):212-20. PubMed ID: 19423374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
    Hong X; Kumar AB; Ronald Scott C; Gelb MH
    Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
    Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aicardi-Goutières syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy.
    Tise CG; Morales JA; Lee AS; Velez-Bartolomei F; Floyd BJ; Levy RJ; Cusmano-Ozog KP; Feigenbaum AS; Ruzhnikov MRZ; Lee CU; Enns GM
    Am J Med Genet A; 2021 Jun; 185(6):1848-1853. PubMed ID: 33683010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy.
    Natarajan A; Christopher R; Palakuzhiyil SV; Chandra SR
    Mol Genet Metab Rep; 2021 Mar; 26():100720. PubMed ID: 33552912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Testing for 6 Lysosomal Storage Disorders and X-Adrenoleukodystrophy in Dried Blood Spots by Tandem Mass Spectrometry.
    Tortorelli S; Turgeon CT; Gavrilov DK; Oglesbee D; Raymond KM; Rinaldo P; Matern D
    Clin Chem; 2016 Sep; 62(9):1248-54. PubMed ID: 27440509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
    Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
    Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantitation of hexacosanoyl lysophosphatidylcholine, amino acids, acylcarnitines, and succinylacetone during FIA-ESI-MS/MS analysis of dried blood spot extracts for newborn screening.
    Haynes CA; De Jesús VR
    Clin Biochem; 2016 Jan; 49(1-2):161-5. PubMed ID: 26432925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.